S-1 plus apatinib followed by salvage esophagectomy for irinotecan-refractory small cell carcinoma of the esophagus: A case report and review of the literature

RATIONALE: Small cell carcinoma of the esophagus (SCCE) is an uncommon but lethal disease characterized by dismal prognosis. Only 10% of advanced SCCE patients survive longer than 1 year. Resection is a choice for limited-stage cases, whereas the optimal treatment regimen for primary SCCE is yet to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chu, Yu, Guang-Mao, Zhang, Miao, Wu, Wenbin, Gong, Long-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220406/
https://www.ncbi.nlm.nih.gov/pubmed/32011517
http://dx.doi.org/10.1097/MD.0000000000018892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220406/
https://www.ncbi.nlm.nih.gov/pubmed/32011517
http://dx.doi.org/10.1097/MD.0000000000018892

Ejemplares similares